At our hospital, we incorporate catheter treatment into various fields of medicine, as it causes less physical and mental stress in patients and allows for rapid post-surgical recovery. In the case of valvular heart disease (cardiac valvulopathy), such as in mitral stenosis, the standard procedure is to use a catheter to perform a commissurotomy during open-heart surgery. For the treatment of aortic valvular stenosis, transcatheter aortic valve replacement (TVAR) is the international standard among state-of-the-art procedures. In cases of heart surgery, we give the utmost consideration to the patient’s quality of life (QOL) and the degree of invasiveness; therefore, we either repair the mitral valve, a procedure that requires no postoperative warfarin, or replace it with a homograft or heterograft. In those cases where invasive surgery is necessary, we use a robotic surgery system.
In the treatment of cerebral diseases, we use catheter treatment for cases of cerebral aneurysm and cerebral malformation, which can potentially cause subarachnoid hemorrhages, a condition observed more commonly among Asians. We lead the nation in our achievements in the fields of cerebral catheterizations and advanced hybrid treatment (combined application of gamma knife, cerebrovascular bypass surgery, etc.), both in the number of surgeries performed for intractable cases and in performance results.
Because a child’s heart is small and conditions are difficult to stabilize, extremely sophisticated surgical skills are required for the treatment of congenital heart diseases. Our hospital is considered a worldwide leader in the treatment of complex congenital heart diseases. Since our hospital was founded in 1977, we have performed approximately 7,800 surgeries using an artificial heart-lung machine, over 1,000 neonatal surgeries, and over 400 Fontan surgeries. Furthermore, we utilize catheter treatment as a minimally invasive procedure for relatively simple conditions, including such cardiac malformations as interatrial septal defects and patent ductus arteriosus.
The National Cerebral and Cardiovascular Center was established in 1977 as a national center for the research and treatment of intravascular pathology. One of its major features is the full integration of its hospital and research laboratories. This system allows us to directly tie issues at the clinical practice level to research findings, and vice versa. As a result, we have fostered advancements in innovative medical treatments, such as the world’s most advanced artificial heart. Another feature of the center is its combined foundation in cardiovascular and cerebrovascular medicine, which enables us to provide optimal medical care through the collaboration of specialists in each field, making us one of the few medical facilities in the world specializing in both the brain and heart. Because of the increasing number of clinical conditions with risks of complications in both areas, our center has drawn attention worldwide for its unification of these two fields.
|Catheter-Based Treatment for Cardiovascular Disease|
|Percutaneous Coronary Intervention (PCI)||505|
|Arrhythmia Treatment Using Catheter Ablation
(Percutaneous Transluminal Myocardial Ablation)
|Aortic Stent Grafting||112|
|Catheter-Based Treatment for Obstructive Arteriosclerosis (of the Legs)||98|
|Catheter-Based Treatment for Cerebrovascular Disease||154|
|Cardiac Cathetererization Test / Therapy||691|
|Catheter Procedure to Close Atrial Septal Defect||98|
Our comprehensive specialty is catheter-based diagnosis and treatment. In addition to the treatments described above, we perform a number of catheter ablations for arrhythmias. Because of our extensive surgical expertise and catheter-based procedures, we are confident that we will be able to select the most appropriate choice of treatment for each individual patient depending upon his/her pathological conditions, whether it be catheter treatment, surgery, or another treatment. Furthermore, our center is equipped with a hybrid operating room in which both catheter treatment and surgery can be performed at the same time. In treating aortic aneurysms, for instance, a surgical procedure and catheter-based endovascular aneurysm (stent grafting) repair can be performed together, depending upon the location of the lesion.
This outstanding approach causes the patient less physical stress, and surgery requires less time.
In addition, our center is recognized worldwide for its abundant expertise and highly successful performance results in its pioneering treatment of the relatively rare Moyamoya disease (primarily found in East Asia), bypass surgery of severe coronary artery lesions as an after-effect of Kawasaki disease, and diagnosis and treatment of Brugada syndrome (also primarily found in Asia). In Japan, pulmonary hypertension, a rare and intractable disease, is treated almost exclusively at our center, and our performance records are outstanding based on international comparisons.
Dr. Hiroaki Naito
If you have an intractable cardiovascular disease, please consult us at our center. We have been accepting children from the Middle East and other countries, particularly for the treatment of congenital heart diseases, with which we have abundant experience and a record of success. As Japan’ s leading hospital for cardiovascular disease, and as one of the very few hospitals in the world that offers concurrent medical care for cerebral and cardiovascular diseases, we are confident that our collaborative team of specialists in both fields can offer you the optimal treatment for a wide variety of illnesses.
Our fundamental vision of medical care is to share medical information and responsibility with our patients when making treatment decisions, and to proceed with diagnosis and treatment together. It is our sincere hope to provide the best medical care possible to our international patients under such a partnership between patients and healthcare professionals.
We are particularly interested in hearing from patients with complex congenital heart disease.
Please contact us for a consultation regarding admission to our hospital based on your medical
information and/or image data.
You and your family can stay at the nearby McDonald House, at a hotel, or other lodging facility.
|External View of Our Center||Hybrid Operating Room
In this room, both diagnosis and treatment using catheters and surgical procedures can be performed concurrently.
|Inside Our Ward
Specialists in each medical field work collaboratively as a team to take care of patients.
Department of Cardiovascular Internal Medicine (Arrhythmia, Pulmonary Circulation, Heart Failure, Coronary Disease, Vasculature, and Cardiovascular Intensive Care Divisions), The Hypertension/ Nephrology Division, Diabetes/Metabolism Division, Department of Cardiovascular Surgery (Cardiac Surgery, Pediatric Cardiac Surgery and Vascular Surgery Divisions), Department of Transplants, Cerebrovascular Internal Medicine Division, Neurosurgery Division, Pediatric Cardiovascular Medicine Division, Department of Perinatology/Gynecology, Anesthesiology Division, Neuropsychiatry Division, Genetic Counseling Room, Central Clinical Department, Department of Prophylactic Examinations
Cash, Credit Card (MUFG, UFJ, DC, Nicos, VISA, MasterCard, American Express, Diners Club, JCB)
5-7-1 Fujishirodai, Suita-shi, Osaka 565-8565
|10 minutes from Senri-chuo Station
(Subway Midosuji Line or the Kita-Osaka
Kyuko Railway) by car
3 minutes from the Hankyu Railway
Senri Line Kita-senri Station by car
|20 minutes from Osaka International Airport (Itami Airport) by car|